We investigated the immunohistochemical expression of bcl-2 in 55 non small
cell lung cancer patients in order to understand if the altered expression
of this gene is involved in the development of this kind of neoplasm. Our
results showed bcl-2 immunopositivity to be a frequent event in non small c
ell lung cancer (54.5%) with a higher expression in squamous carcinomas com
pared to adenocarcinomas (p=.04). In addition, we found a positive correlat
ion between bcl-2 expression levels and nodal status (p<.003). We suggest t
hat bcl-2 immunostaining could be considered as marker of locoregional inva
sivity.